Hepatic arterial embolization for unresectable hepatocellular carcinomas: do technical factors affect prognosis?

A retrospective comparative study of epirubicin–lipiodol emulsion and cisplatin–lipiodol suspension for use with transcatheter arterial chemoembolization for treatment of hepatocellular carcinoma

(2010) Hiraku Yodono et al.   ANTI-CANCER DRUGS

Complete Necrosis After Transarterial Chemoembolization Could Predict Prolonged Survival in Patients with Recurrent Intrahepatic Hepatocellular Carcinoma After Curative Resection

(2009) Ju Hyun Shim et al.   ANNALS OF SURGICAL ONCOLOGY

Prospective Randomized Comparison of Chemoembolization with Doxorubicin-Eluting Beads and Bland Embolization with BeadBlock for Hepatocellular Carcinoma

(2009) Katerina Malagari et al.   CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY

Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study

(2009) Johannes Lammer et al.   CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY

Clinical impact of selective transarterial chemoembolization on hepatocellular carcinoma: A cohort study

(2009) Rodolfo Sacco et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Histopathological findings after ultraselective transcatheter arterial chemoembolization for hepatocellular carcinoma

(2008) Shiro Miyayama et al.   HEPATOLOGY RESEARCH

Multivariate Analysis of the Predictors of Survival for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Focusing on uperselective Chemoembolization

(2008) Suk Kyeong Ji et al.   KOREAN JOURNAL OF RADIOLOGY